<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00604227</url>
  </required_header>
  <id_info>
    <org_study_id>M2005</org_study_id>
    <nct_id>NCT00604227</nct_id>
  </id_info>
  <brief_title>Pulmonary Function at High-Altitude</brief_title>
  <official_title>Interstitial Pulmonary Edema After Rapid Ascent to High Altitude (Margherita Hut, 4559 m)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on the findings of decreased vital capacity, decreased FEV1 and increased closing
      volume after ascent to high altitude, some investigators suggest the presence of a
      subclinical high altitude pulmonary edema (HAPE). Since these parameters are only indirect
      measures of pulmonary interstitial fluid accumulation, the aim of this study is to examine
      the effects of broncho-constriction on the increase of closing volume by extensive lung
      function testing in healthy mountaineers at low altitude and on the Margherita Hut (4559 m).
      As has been done in earlier studies, conventional thorax radiographs are used for
      verification of HAPE. In this study, the determination of the thoracic fluid quantity will be
      completed by measurements of thoracic impedance. In addition markers of pulmonary endothelial
      function will be assessed to get further insight into the regulation of pulmonary vascular
      tone at altitude and in particular into the pathophysiology of HAPE.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">August 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>development of HAPE</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of lung function parameters from low to high altitude</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>markers of pulmonary endothelial function</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quantification of pulmonary interstitial fluid</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Pulmonary Edema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high altitude exposure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxic Exposure</intervention_name>
    <description>ascent to 4559 m within 24 h without prior acclimatization</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mountaineering ability required for reaching the Margherita hut (4559 m)

        Exclusion Criteria:

          -  Borne above 1500 m

          -  Subjects with internal medical diseases like all cardiac diseases, all pulmonary
             diseases, Diabetes mellitus, infectious diseases, thyroid diseases, malignant
             diseases, hepatic or renal diseases,

          -  (Known) hypersensitivity to salbutamol or to another component of sultanol® or
             lidocaine, or to another component of xylocain® pump spray

          -  Intake of drugs, especially nifedipine, acetazolamide and glucocorticoids or of drugs
             interacting with sultanol® or xylocain® pump spray

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Dehnert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc M Berger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Bärtsch, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sports Medicine, University Hospital</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2008</study_first_submitted>
  <study_first_submitted_qc>January 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2008</study_first_posted>
  <last_update_submitted>January 29, 2008</last_update_submitted>
  <last_update_submitted_qc>January 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2008</last_update_posted>
  <keyword>high altitude pulmonary edema</keyword>
  <keyword>pulmonary interstitial fluid</keyword>
  <keyword>pulmonary function testing</keyword>
  <keyword>hypoxia</keyword>
  <keyword>pulmonary endothelial function</keyword>
  <keyword>high altitude exposure without prior acclimatization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

